Inflammation spin-off launchedLife science venture capital group Epidarex has launched Nodthera Ltd, a biotech based on research by Poland-based drug discovery company Selvita. The start-up aims to develop novel inhibitors of the … more ➔
GSK picks up asthma mAbGlaxoSmithKline has in-licensed Janssens anti-IL-33R monoclonal antibody for severe asthma. The British drugmaker is paying €208m up front for the mAb. more ➔
Brexit: calls for reassuranceIn view of the Brexit, research academies across Britain are calling for a bold commitment from the government. The Royal Society President urges the UK government to underwrite the research of British … more ➔
Funds for MDx manufactureBelgian molecular diagnostics company Biocartis Group NV has raised €55m and will use the funds mainly to expand manufacturing capacities for its PCR-based molecular diagnostics system Idylla. more ➔
IPO pay off for French biotechsEuropes first gene therapy company has floated on Euronext: Gensight raised €40m in its IPO. And it is not the only French company that has taken the leap in an uncertain market climate – Alzheimers … more ➔
Out of this world: UK tech in spaceWhen NASA blasted off to the International Space Station on Monday morning, it had UK tech on board. A miniature DNA sequencer from Oxford Nanopore will be used to keep an eye on the ISS atmosphere – … more ➔
Cell Medica picks up antibody techCell Medica has acquired Swiss antibody specialist Delenex Therapeutics. The deal nets the British cellular therapeutics developer Delenex proprietory antibody fragment platform Pentrabody. more ➔
Themis bags vaccine licenseVienna-based vaccine specialist Themis Bioscience GmbH has secured broad access to a promising virus vaccine vector tech by extending its license agreement with French Institut Pasteur. Its goal: to … more ➔
Medivation opens books to SanofiCalifornian biopharma Medivation has agreed to confidential negotiations with its suitors, in particular the French pharmaceutical company Sanofi, which aggressively has buffeted the cancer therapy specialist … more ➔
Next chapter in Dx IP disputeThe European Commission started an investigation into Illuminas and Sequenoms 2014 patent agreement, UK-competitor Premaitha Health said. The two US companies had agreed to pool their Noninvasive … more ➔
